BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19698926)

  • 1. Gene expression profiling in acute myeloid leukaemia (AML).
    Bacher U; Kohlmann A; Haferlach C; Haferlach T
    Best Pract Res Clin Haematol; 2009 Jun; 22(2):169-80. PubMed ID: 19698926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
    Bacher U; Kohlmann A; Haferlach T
    Br J Haematol; 2009 Jun; 145(5):555-68. PubMed ID: 19344393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.
    Bacher U; Kohlmann A; Haferlach T
    Brief Funct Genomic Proteomic; 2009 May; 8(3):184-93. PubMed ID: 19474126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies.
    Bacher U; Kohlmann A; Haferlach T
    Cancer Treat Rev; 2010 Dec; 36(8):637-46. PubMed ID: 20570445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
    Baldus CD; Bullinger L
    Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and genetic subtypes of leukemia combining gene expression and flow cytometry.
    Basso G; Case C; Dell'Orto MC
    Blood Cells Mol Dis; 2007; 39(2):164-8. PubMed ID: 17588788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in acute myeloid leukemia.
    Bullinger L; Valk PJ
    J Clin Oncol; 2005 Sep; 23(26):6296-305. PubMed ID: 16155012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in AML in relation to (ab)normal karyotype.
    Stone RM
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):523-8. PubMed ID: 19959103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
    Verhaak RG; Valk PJ
    Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
    Baldus CD; Mrózek K; Marcucci G; Bloomfield CD
    Br J Haematol; 2007 Jun; 137(5):387-400. PubMed ID: 17488484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in acute myeloid leukaemia.
    de Jonge HJ; Huls G; de Bont ES
    Neth J Med; 2011 Apr; 69(4):167-76. PubMed ID: 21527803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnosis of acute myeloid leukaemia enhanced by using DNA microarrays].
    Löwenberg B; Delwel HR; Valk PJ
    Ned Tijdschr Geneeskd; 2005 Mar; 149(12):623-5. PubMed ID: 15813428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
    Marcucci G; Haferlach T; Döhner H
    J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
    Sritana N; Auewarakul CU
    Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
    Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
    Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?
    Willman CL
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):21-8. PubMed ID: 18342809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically useful prognostic factors in acute myeloid leukemia.
    Ferrara F; Palmieri S; Leoni F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):181-93. PubMed ID: 17996460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population.
    Ahmad F; Mandava S; Das BR
    Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation.
    Øyan AM; Bø TH; Jonassen I; Gjertsen BT; Bruserud Ø; Kalland KH
    Int J Oncol; 2006 May; 28(5):1065-80. PubMed ID: 16596222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.